Literature DB >> 1612230

The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy.

A A Sima1, M B Brown, A Prashar, S Chakrabarti, C Laudadio, D A Greene.   

Abstract

The nerve fibre loss, atrophy and injury of diabetic peripheral polyneuropathy and their responses to metabolic intervention have been studied by morphometric analysis of sural nerve biopsies. The magnitudes and sources of intra- and inter-individual variation in these morphometric measures have not been investigated previously in a systematic manner. Morphometric parameters of nerve fibre damage were measured in four separate fascicles from bilateral sural nerve specimens obtained post-mortem from 13 diabetic and 13 non-diabetic subjects. Intra- and inter-individual coefficients of variation were computed and compared to the magnitude of the differences between normal and diabetic subjects. Several morphometric variables emerged as highly sensitive and reproducible measures of nerve fibre damage suitable for clinical studies of diabetic peripheral polyneuropathy. These observations provide a rational basis for the design of future clinical trials employing morphometric end-points.

Entities:  

Mesh:

Year:  1992        PMID: 1612230     DOI: 10.1007/bf00400485

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy.

Authors:  P J Dyck; P C O'Brien
Journal:  Diabetes Care       Date:  1989-10       Impact factor: 19.112

2.  Improvement in nerve conduction following treatment in newly diagnosed diabetics.

Authors:  J D Ward; C G Barnes; D J Fisher; J D Jessop; R W Baker
Journal:  Lancet       Date:  1971-02-27       Impact factor: 79.321

3.  Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients.

Authors:  G Gregersen
Journal:  Diabetologia       Date:  1968-11       Impact factor: 10.122

4.  Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps.

Authors:  A Pietri; A L Ehle; P Raskin
Journal:  Diabetes       Date:  1980-08       Impact factor: 9.461

5.  Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat.

Authors:  A A Sima; S A Lattimer; S Yagihashi; D A Greene
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

6.  Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil.

Authors:  A A Sima; V Bril; V Nathaniel; T A McEwen; M B Brown; S A Lattimer; D A Greene
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

7.  Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.

Authors:  R J Graf; J B Halter; M A Pfeifer; E Halar; F Brozovich; D Porte
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

8.  Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy.

Authors:  P J Dyck; A Lais; J L Karnes; P O'Brien; R Rizza
Journal:  Ann Neurol       Date:  1986-05       Impact factor: 10.422

9.  Reversible and irreversible nodal dysfunction in diabetic neuropathy.

Authors:  T Brismar; A A Sima; D A Greene
Journal:  Ann Neurol       Date:  1987-05       Impact factor: 10.422

10.  Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy.

Authors:  P J Dyck; J L Karnes; J Daube; P O'Brien; F J Service
Journal:  Brain       Date:  1985-12       Impact factor: 13.501

View more
  5 in total

Review 1.  Measurement of somatic neuropathy for clinical practice and clinical trials.

Authors:  L V Scott; S Tesfaye
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

2.  Advanced Diabetic Neuropathy: A Point of no Return?

Authors:  Petr Boucek
Journal:  Rev Diabet Stud       Date:  2006-11-10

Review 3.  Diabetic neuropathy in the elderly.

Authors:  A A Sima; D A Greene
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

4.  The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat.

Authors:  M Kamijo; P V Cherian; A A Sima
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

5.  Reproducibility in nerve morphometry: comparison between methods and among observers.

Authors:  Antônio Paulo da Costa Bilego Neto; Fernando Braga Cassiano Silveira; Greice Anne Rodrigues da Silva; Luciana Sayuri Sanada; Valéria Paula Sassoli Fazan
Journal:  Biomed Res Int       Date:  2013-06-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.